Skip to main content
Premium Trial:

Request an Annual Quote

Michael Nemzek

MedGenome has appointed Michael Nemzek as chief commercial officer. Nemzek has held executive leadership positions in both public companies and private companies, including RareCyte, Affymetrix, and Velocity11. He also holds advanced degrees in chemistry from North Carolina State University and in management from the University of Maryland.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.